News Reduction of share capital Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital Continue Reading Previous FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary FibrosisNext Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss Related Stories News playX Receives the ‘Enterprise Award’ at the Asia Golden Star Awards in Tokyo News Zhibao Technology Announces Receipt of Nasdaq Deficiency Letter News Fairfax County and Penzance Officials Break Ground on Next-Generation Digital Infrastructure Project to Power the World’s Deep Tech Future Data Center News Dynamic Expands to Loudoun County, Virginia — Meeting Customer Demand for Secure, Sustainable ITAD and Data Center Services in “Data Center Alley” News Aptean Launches AppCentral 2.0: The AI Platform Purpose-Built for Industries News Blue Lake Casino & Hotel and Quick Custom Intelligence (QCI) Extend Partnership to Further Enhance Guest Experience and Drive Profitability
